original ) (raw )Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom (FACT-ES) score in postmenopausal ER-positive, HER2- negative metastatic breast cancer with low sensitivity to endocrine therapy
Naruto Taira
Research Square (Research Square), 2021
View PDFchevron_right
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B
Anthony Howell
Breast Cancer Research and Treatment, 1999
View PDFchevron_right
Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review
Alberto Montero
PharmacoEconomics - open, 2018
View PDFchevron_right
HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE Original Article
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2018
View PDFchevron_right
Endocrine symptom assessment in women with breast cancer: what a simple “yes” means
Karin Ribi
Supportive Care in Cancer, 2007
View PDFchevron_right
Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer
Sara Edmond
Journal of Geriatric Oncology, 2019
View PDFchevron_right
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
Teresa Gamucci , Andrew Bottomley
European Journal of Cancer, 2004
View PDFchevron_right
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
Martin Stockler
2010
View PDFchevron_right
Predictors of response to second-line endocrine therapy for breast cancer
Sarah Pinder
Breast Cancer Research and Treatment, 1997
View PDFchevron_right
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)
Fabio Franke
Therapeutic Advances in Medical Oncology
View PDFchevron_right
Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials
Artur Katz
Cancer Treatment Reviews, 2012
View PDFchevron_right
Health-Related Quality of Life in Women With Breast Cancer Undergoing Treatment With Hormonal Therapy – A Review Study
lamya alnaim
The Journal of Breast Health, 2022
View PDFchevron_right
Reliability and Validity of the Functional Assessment of Cancer Therapy-Breast Quality-of-Life Instrument
Gonzalo Fleming
View PDFchevron_right
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs
Naruto Taira
Breast Cancer, 2020
View PDFchevron_right
Review Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials
Andrew Bottomley
View PDFchevron_right
Quality of Life in Early Breast Cancer Patients: A Prospective Observational Study Using the FACT-B Questionnaire
Annamaria Porreca
In Vivo, 2021
View PDFchevron_right
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
O.R. GUICHERIT
Breast Cancer Research and Treatment
View PDFchevron_right
EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review
Andrew Bottomley
View PDFchevron_right
Deterioration of Quality of Life of High-Risk Breast Cancer Patients Treated with High-Dose Chemotherapy: The PEGASE 01 Quality of Life Study
Patricia Marino
Value in Health, 2008
View PDFchevron_right
The Prognostic Role of Quality of Life Assessment in Breast Cancer
James Grutsch
The Breast Journal, 2011
View PDFchevron_right
Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock
Jeanne Black
JNCI Journal of the National Cancer Institute, 2003
View PDFchevron_right
Does Treatment Impact on the Quality of Life in Breast Cancer Patients? A Comparative Study Between Treatments
Natasha Alcocer
2021
View PDFchevron_right
Quality of Life Assessment in Women with Breast Cancer: A Prospective Study Including Hormonal Therapy
Fatma Sert , Zeynep Ozsaran , Senem Demirci
Journal of Breast Cancer, 2013
View PDFchevron_right
The prognostic association of health-related quality of life scores with survival in breast cancer
James Grutsch
Supportive Care in Cancer, 2007
View PDFchevron_right
Clinical Studies on Hormonal Status in Breast Cancer and its Impact on Quality of Life(QOL)
Hajira Fatima
Journal of Cancer Science & Therapy, 2009
View PDFchevron_right
The Role of Health-Related Quality of Life in Early Discontinuation of Chemotherapy for Breast Cancer
Lisa Richardson
The Breast Journal, 2007
View PDFchevron_right
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
A. Goldhirsch , Alan Coates
Annals of Oncology, 2009
View PDFchevron_right
Systematic overview of quality of life studies for breast cancer
Noriyuki Katsumata , Chikako Yamauchi
Breast Cancer, 2002
View PDFchevron_right
Quality of life measurement in breast cancer patients
N. Boyd
British journal of cancer, 1985
View PDFchevron_right
Health Related Quality of Life in Breast Cancer Patients Undergoing Current Chemotherapy Protocols
nahid hatam
2012
View PDFchevron_right
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
John Forbes , A. Goldhirsch , Alan Coates
2004
View PDFchevron_right
Comparative study of quality of life in breast cancer patients receiving two different chemotherapy regimens using European Organization for Research and Treatment of Cancer Quality of Questionnaire-Core 30 questionnaire module; for tolerability and safety
Kiran Haridas
International Journal of Basic and Clinical Pharmacology, 2015
View PDFchevron_right
Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study
Andrew Bottomley
Journal of Clinical Oncology, 2004
View PDFchevron_right